Biofrontera Inc.
BFRI
$0.86
$0.0121.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.53M | -17.76M | -12.84M | -13.51M | -23.09M |
| Total Depreciation and Amortization | 1.06M | 1.15M | 1.22M | 1.16M | 1.11M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.30M | 128.00K | -7.36M | -6.15M | 586.00K |
| Change in Net Operating Assets | 3.70M | 6.21M | 856.00K | -421.00K | -3.13M |
| Cash from Operations | -11.06M | -10.27M | -18.12M | -18.92M | -24.53M |
| Capital Expenditure | 44.00K | -10.00K | 0.00 | 0.00 | -48.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -50.00K | 7.00K | 71.00K | 453.00K | 681.00K |
| Cash from Investing | -6.00K | -3.00K | 71.00K | 453.00K | 633.00K |
| Total Debt Issued | 4.05M | 4.05M | 11.70M | 19.55M | 25.25M |
| Total Debt Repaid | -2.45M | -4.32M | -13.81M | -20.77M | -23.21M |
| Issuance of Common Stock | 7.44M | 15.10M | 19.61M | 19.61M | 12.17M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9.04M | 14.84M | 17.50M | 18.39M | 14.21M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.03M | 4.56M | -549.00K | -74.00K | -9.69M |